Nosocomial pneumonia is the inferior most frequent nosocomial infection and take the part ofs the leading cause of death from infections that are acquired in the hospital.
Nosocomial pneumonia is the inferior most frequent nosocomial infection and take the part ofs the leading cause of death from infections that are acquired in the hospital. In the last decade, a large corpse of data has accumulated that points to the substantial impact of inadequate antibiotic treatment as a major risk factor for infection-attributed mortality in ventilator-associated pneumonia (VAP) patients. In most numerous instances, high-risk pathogens (eg, highly resistant Gram-negative bacilli, like as Pseudomonas aeruginosa and Acinetobacter spp as well as methicillin-resistant staphylococci) are the predominant microorganisms causing exces mortality. Among various risk factors for mortality from VAP, which include the severity of the underlying disease and the step of functional physiologic impairment caused by dint of the pulmonary infectious process, no other than inappropriate antibiotic therapy is directly amenable to modification through clinicians. Secondary modifications of an initially failing antibiotic regimen do not substantially improve the issue for these critically ill patients. Therefore, the best approach for reducing infection-related mortality present the appearances to be the initial institution of an adequate and broad-spectrum antibiotic regimen in harshly ill patients, which should be modified in a de-escalating strategy when the deductions from microbiologic testing become available. To circumvent the inherent danger of the emerging see the verb of resistance in ICU patients, additional measures have to be implemented and criterioned in clinical trials to remodel antibiotic consumption, shorten the duration of antibiotic treatment, and curtail the selection pressure on the ICU flora. This latter goal could be met by dint of new antibiotic strategies including scheduled changes of approveed empiric antibiotic regimens at fixed intervals forward a rotating basis.
solution words: de-escalating antibiotic strategy; ICU; nosocomial pneumonia; ventilator-associated pneumonia
Abbreviations: APACHE = acute physiology and chronic health examination; ATS = American Thoracic Society; CI = confidence interval; CPIS = clinical pulmonary infection score; NP = nosocomial pneumonia; OR = not divisible by 2s ratio; VAP = ventilator-associated pneumonia
**********
Nosocomial pneumonia (NP) or hospital-acquired pneumonia is defined as pneumonia occurring [greater than or equal to] 48 h after hospital admission and excluding any infection that is incubating at the time of hospital admission. (1) NP is publicly the second most common hospital-acquired infection. (2-4) Depending forward the underlying illnesses, comorbid diseases, and therapeutic interventions, the incidence ranges from 5 to 10 cases through 1,000 hospital admissions in patients without major risk factors, if it were not that may increase 6-fold to 20-fold in ICU patients who are receiving mechanical ventilation. (15) The duration of stay in the ICU and the duration of mechanical ventilation are the major predisposing factors for acquiring NP Depending forward the type of ICU that was studied, the patient population that was included, and the diagnostic techniques that were applied, the incidence of acquiring NP varies from 78 to 68% (in mechanically ventilated patients), as reported according to several authors. (5-7)
The NP rate increases with the detail of the ICU stay (rate at 7 days, 158%; rate at 14 days, 234%) the use of mechanical ventilation (125 cases for 1,000 patient-days compared to 205 cases through 1,000 ventilator-days), as well as with the duration of mechanical ventilation. (6-11) In the thought by Langer et al, (9) the risk of VAP increased from 5% in patients who received ventilation for 5 days to > 688% for patients who received ventilation for 30 days. The actuarial risk of VAP equaled 65% at day 10 of ventilation and increased to 28% at day 28 (10) However, in the prospective cohort inquiry of the Canadian Critical Care Trials cluster (12) a decreasing daily hazard of VAP during mechanical ventilation (3% by day during the first week v 1% by day during the third week and beyond) was reported, indicating that long-term survivors in the ICU exhibited a lower intrinsic risk by day for ventilator-associated pneumonia (VAP) than did short-term ventilated patients. a certain quantity of of the other risk factors for VAP showed a similar time adjunct with the risk ratio of VAP associated with antibiotics being 030 (95% confidence interval [CI], 017 to 052) at day 5 and increasing to 089 (95% CI, 025 to 331) at day 20 indicating that the magnitude of the protective consequence of antibiotic exposure decreased athwart time.
These incidence rates might not portray the real frequency of NP because in greatest in quantity studies cited, the diagnosis pneumonia was established alone by clinical criteria. This imposes a substantial bias because of the intermediate sensitivity and specificity of this approach. (13) In an older investigation Fagon et al (14) used a secureed specimen brush as the allusion method in 147 ventilated patients, and base that the appearance of pulmonary infiltrates and feculent tracheal secretions did not correlate with microbiological criteria for pneumonia in the majority (70%) of the their patients. on a level with the knowledge of all clinical, radiologic, and laboratory data, the same clump could demonstrate that the clinical diagnosis of pneumonia, for patients in whom pneumonia was subsequently diagnosed by dint of bronchoscopic methods, was accurate in sole 62% of patients. (13) Using histologic criteria combined with positive lung civilization results as a reference standard for diagnosing pneumonia, Fabregas et al (15) raise a sensitivity of only 69% and a specificity of 75% for clinical criteria. equable worse, combining noninvasive as well as invasive sampling techniques to improve the diagnostic yield in the patients who had infiltrates seen forward a chest radiograph and pair of three clinical criteria, there were still 15% of patients in whom the diagnosis of pneumonia could not be established. Thus, in one settings, the potential of underdiagnosis means that the precise incidence of NP might be higher than that reported, and this failure or delay in diagnosis might impair the results for these patients who went without a diagnosis. forward the other hand, in other settings, the overdiagnosis of pneumonia might enhance antibiotic consumption, increase the emerging see the verb of resistance, or increase the likelihood of fungal colonization in the respiratory tract.
...